112 Pill - beige round, 8mm
Generic Name: sitagliptin
Pill with imprint 112 is Beige, Round and has been identified as Januvia 50 mg. It is supplied by Merck & Company Inc.
Januvia is used in the treatment of Diabetes, Type 2 and belongs to the drug class dipeptidyl peptidase 4 inhibitors. There is no proven risk in humans during pregnancy. Januvia 50 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 112
Januvia
- Generic Name
- sitagliptin
- Imprint
- 112
- Strength
- 50 mg
- Color
- Beige
- Size
- 8.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Dipeptidyl peptidase 4 inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Merck & Company Inc.
- Inactive Ingredients
-
calcium phosphate dibasic anhydrous,
croscarmellose sodium,
magnesium stearate,
microcrystalline cellulose,
ferric oxide red,
sodium stearyl fumarate,
magnesium silicate,
titanium dioxide,
ferric oxide yellow
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00006-0112 | Merck |
| 54868-6031 (Discontinued) | Physicians Total Care Inc. (repackager) |
Related images for "112"
More about Januvia (sitagliptin)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (138)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: dipeptidyl peptidase 4 inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.